Home/Filings/4/0000950170-25-025030
4//SEC Filing

SUMER JACQUELYN L 4

Accession 0000950170-25-025030

CIK 0001789972other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 6:00 PM ET

Size

7.2 KB

Accession

0000950170-25-025030

Insider Transaction Report

Form 4
Period: 2025-02-19
SUMER JACQUELYN L
Chief Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-19+100,000100,000 total
    Exercise: $9.43Exp: 2035-02-19Common Stock (100,000 underlying)
  • Award

    Common Stock

    2025-02-19+50,000140,651 total
Footnotes (2)
  • [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
  • [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Documents

1 file

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001844824

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:00 PM ET
Size
7.2 KB